The idea for Vibe Bio began in 2021 when our founder, Alok, had his first child.
In this circumstance, it became a passion for our team to understand why medicines aren’t being developed when patients are suffering. Through this process, our insight became that the challenge isn’t finding a cure, but funding it.So, we set out to build Vibe Bio.
We are a community of patients, scientists, and partners committed to identifying, funding and developing promising treatments. Through our travels, it became clear that there were common pinchpoints where medicines often get stuck in development. These bottlenecks are often tied to inflection points and capital becomes hard to access.
Our Team
A few things we believe
- All of us should have the power to pursue a cure.Every scientist, patient, family member, etc. with a life-altering disease — no matter how rare it is — should feel a part of a community with the power to pursue their cure. But too many promising treatments to overlooked diseases are abandoned because the treatments they need are considered too costly and too risky.
- A mission-driven approach to developing medicines.Vibe Bio is building a community of patients, scientists, and partners to identify promising treatments and fund their development in innovative ways. For the first time, we’re scaling biotech funding to support neglected and underfunded drug programs — and giving patient communities unprecedented awareness in the process.
That’s why Vibe Bio is creating a different, mission-driven approach to developing medicines; one that taps into new sources of financing for biotech startups. - Patients, not profits or politics, should drive drug discovery.The biggest obstacle to treating patients with overlooked diseases isn’t finding potential treatments — it’s funding them. When those working on promising treatments are empowered to lead the search for a cure, fewer families suffer needlessly and no one has to forge the path to a happier, healthier life alone.
- Unlocking capital to help biotechs reach inflection pointsAccess to capital is critical in propelling biotechnology companies and their drug programs towards pivotal inflection points. As biotechs work tirelessly to improve the lives of millions, access to sufficient funding is essential to fuel their groundbreaking research, drive innovation, and accelerate the translation of novel discoveries into real-world applications. By providing strategic financial resources, we not only support the growth of these cutting-edge companies but also contribute to the advancement of the entire biotech ecosystem.
